Make Your Voice Heard on Lupus Drug Development
En Español
Email Sign Up
Give
Search
En Español
Sign Up for Updates
Who We Are
About Us
Our Impact
Strategic Plan Highlights
Our History
Our Commitment to DE&I
Financials
Careers
Leadership and Partners
Board of Directors
Research Committee of the Board
Scientific Advisory Board
Leadership and Partners
Executive Staff
Young Leaders Board
Complexity of Lupus
Why Is Lupus So Complex?
About Lupus
Symptoms
How is Lupus Diagnosed?
Treatment
Educational Resources
Our Research
About Our Research
Research Roadmap
Research We Fund
Get Involved in Research
Lupus Nexus
Participate in the Lupus Landmark Study
Lupus Therapeutics, LLC
For Researchers
Funding Opportunities
Funded Research
Research Partners
Scientific Resources
Research Contacts
LRA Reviewers 2022 – 2023
Press
Stories & News
Get Involved
Give
Online Donation
Other Ways to Give
Sponsorship Opportunities
Research
Find a Clinical Trial
Give to the Lupus Brain Bank
Participate in the Lupus Landmark Study
Events
Join Our Events
Walk
Host an Event
Volunteer
Educate Your Community
Advocate
Advocate
Results
Advocacy News
Contact
Stories & News
News and Stories
Make Your Voice Heard on Lupus Drug Development
The national lupus patient advocacy community is excited to announce that people with lupus will have the chance to be part...
News and Stories
Novel Research Grants Push Discoveries
10 New Grants, 10 New Insights The path to safe and effective treatments and ultimately a cure lies in bold, pioneering...
News and Stories
Aurinia Announces Voclosporin Meets 48-Week Remission Endpoints
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH / TSX:AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global immunology...
Posts pagination
◀︎
1
…
49
50
51
Search Our Site
Search
X
